荷兰血管外科医生对间歇性跛行监督运动疗法的认可度上升
该问卷研究于2015年调查荷兰血管外科医生、研究员及资深住院医师对监督运动疗法(SET)的处方态度,并与2011年调查比较。结果显示SET转诊率无显著变化(2015年81% vs 2011年75%,P=0.295),但对合并慢阻肺患者更愿处方SET(86% vs 69%,P=0.002),而对主髂动脉病变的适应证认可下降(63% vs 76%,P=0.049)。保险报销不足是主要障碍(80%受访者),94%认为SET应完全报销。
要点
- SET转诊率2015年81%与2011年75%无显著差异(P=0.295)。
- 合并慢阻肺的间歇性跛行患者处方SET意愿增加(86% vs 69%,P=0.002)。
- 主髂动脉病变患者SET适应证认可度下降(63% vs 76%,P=0.049)。
核心结论
- 荷兰绝大多数血管外科医生现已普遍接受SET用于间歇性跛行。
- SET在合并心肺疾病的间歇性跛行患者中可能更受欢迎。
- SET在主髂动脉病变中仍未被充分利用。
- 报销被认为是SET成功实施的关键。
研究设计与样本
- 2015年对荷兰血管外科医生、研究员及资深住院医师进行26项问卷调查,并与2011年调查比较。
- 共分析124名受访者数据(82%男性,平均年龄46岁,应答率64%)。
主要发现
- 新发间歇性跛行患者SET转诊率2015年81% vs 2011年75%(P=0.295)。
- 合并慢阻肺患者处方SET的意愿2015年86% vs 2011年69%(P=0.002)。
- 认为SET适用于主髂动脉病变的比例2015年63% vs 2011年76%(P=0.049)。
- 80%受访者认为保险覆盖不足和/或个人经济资源是患者启动SET的主要障碍。
- 94%受访者认为SET应由所有荷兰基本医疗保险全额报销。
临床怎么用
- 对间歇性跛行患者应积极考虑SET转诊,尤其合并慢阻肺者。
- 主髂动脉病变患者中SET应用不足,需加强推广。
- 报销障碍是SET实施的主要瓶颈,应推动医保覆盖。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although supervised exercise therapy (SET) is generally accepted as an effective noninvasive treatment for intermittent claudication (IC), Dutch vascular surgeons were initially somewhat hesitant as reported by a 2011 questionnaire study. Later on, a nationwide multidisciplinary network for SET was introduced in the Netherlands. The aim of this questionnaire study was to determine possible trends in conceptions among Dutch vascular surgeons regarding the prescription of SET. METHODS: In the year of 2015, Dutch vascular surgeons, fellows, and senior residents were asked to complete a 26-item questionnaire including issues that were considered relevant for prescribing SET such as patient selection criteria and comorbidity. Outcome was compared to the 2011 survey. RESULTS: Data of 124 respondents (82% males; mean age 46 years; 64% response rate) were analyzed. SET referral rate of new IC patients was not different over time (2015: 81% vs. 2011: 75%; P = 0.295). However, respondents were more willing to prescribe SET in IC patients with chronic obstructive pulmonary disease (2015: 86% vs. 2011: 69%; P = 0.002). Nevertheless, a smaller portion of respondents found that SET was also indicated for aortoiliac disease (2015: 63% vs. 2011: 76%; P = 0.049). Insufficient health insurance coverage and/or personal financial resources were the most important presumed barriers preventing patients from initiating SET (80% of respondents). Moreover, 94% of respondents judged that SET should be fully reimbursed by all Dutch basic health insurances. CONCLUSIONS: The concept of SET for IC is nowadays generally embraced by the vast majority of Dutch vascular surgeons. SET may have gained in popularity in IC patients with cardiopulmonary comorbidity. However, SET remains underutilized for aortoiliac disease. Reimbursement is considered crucial for a successful SET implementation.
引用
- Hageman D, Lauret GJ, Gommans LNM, et al. Supervised Exercise Therapy for Intermittent Claudication Is Increasingly Endorsed by Dutch Vascular Surgeons. Ann Vasc Surg. 2017. PMID: 28893711. doi:10.1016/j.avsg.2017.08.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。